Acadian Asset Management
PCRX icon

Acadian Asset Management’s Pacira BioSciences PCRX Stock Holding History

Acadian Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,907
Closed -$75K – 2201
2025
Q4 		$75K Buy
2,907
+1,519
+109% +$36.1K ﹤0.01% 1734
2025
Q3 		$35K Sell
1,388
-15,028
-92% -$369K ﹤0.01% 1694
2025
Q2 		$390K Buy
+16,416
New +$414K ﹤0.01% 1188
2020
Q2 		– Sell
-732
Closed -$25K – 2308
2020
Q1 		$25K Buy
+732
New +$30.4K ﹤0.01% 1623
2019
Q4 		– Sell
-249
Closed -$9K – 2020
2019
Q3 		$9K Buy
+249
New +$9.94K ﹤0.01% 1773
2019
Q2 		– Sell
-52,598
Closed -$2M – 1992
2019
Q1 		$2M Sell
52,598
-5,545
-10% -$216K 0.01% 692
2018
Q4 		$2.5M Sell
58,143
-242
-0.4% -$11.3K 0.01% 523
2018
Q3 		$2.87M Buy
+58,385
New +$2.52M 0.01% 485
2016
Q2 		– Sell
-1,610
Closed -$85K – 1498
2016
Q1 		$85K Buy
+1,610
New +$94.2K ﹤0.01% 1054

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return